The Impact of Comorbidity on Costs and Effects of Second-line Treatment among Elderly Metastatic Colon Cancer Patients

被引：0
|
作者：
Woldemichael, A. [1 ]
Onukwugha, E. [1 ]
Zheng, Z. [1 ]
Hanna, N. [1 ]
Seal, B. S. [2 ]
Mullins, C. [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Bayer Healthcare Phamaceuticals, Wayne, NJ USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [1] The impact of comorbidity on costs and effects of second-line treatment among elderly metastatic colon cancer patients.
    Woldemichael, Andinet
    Onukwugha, Ebere
    Zheng, Zhiyuan
    Hanna, Nader
    Seal, Brian S.
    Mullins, C. Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [2] Does First-line Treatment Impact the Cost Effectiveness of Second-line Treatment for Elderly Metastatic Colon Cancer Patients?
    Mullins, C.
    Woldemichael, A.
    Zheng, Z.
    Onukwugha, E.
    Seal, B. S.
    Hanna, N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S141 - S141
  • [3] Does first-line treatment impact the cost-effectiveness of second-line treatment for elderly metastatic colon cancer patients?
    Mullins, C. Daniel
    Woldemichael, Andinet
    Zheng, Zhiyuan
    Onukwugha, Ebere
    Seal, Brian S.
    Hanna, Nader
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [4] Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
    Zheng, Zhiyuan
    Onukwugha, Eberechukwu
    Hanna, Nader
    Bikov, Kaloyan
    Seal, Brian
    Mullins, C. Daniel
    [J]. ADVANCES IN THERAPY, 2014, 31 (07) : 724 - 734
  • [5] Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients
    Zhiyuan Zheng
    Eberechukwu Onukwugha
    Nader Hanna
    Kaloyan Bikov
    Brian Seal
    C. Daniel Mullins
    [J]. Advances in Therapy, 2014, 31 : 724 - 734
  • [6] Second-line treatment of patients with metastatic colorectal cancer
    Rougier, P
    Lepere, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S48 - S54
  • [7] How do first-line treatment and other factors affect the receipt of second-line treatment for elderly metastatic colon cancer patients?
    Zheng, Zhiyuan
    Onukwugha, Ebere
    Hanna, Nader
    Reese, Emily S.
    Seal, Brian S.
    Mullins, C. Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [8] Second-Line Treatment for Metastatic Pancreatic Cancer
    Paluri, Ravi K.
    Kasi, Anup
    Young, Crystal
    Posey, James A.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 106 - 115
  • [9] Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
    Kristen D. Whitaker
    Xiaoliang Wang
    Mustafa Ascha
    Timothy N. Showalter
    Heather G. Lewin
    Gregory S. Calip
    Lori J. Goldstein
    [J]. Breast Cancer Research and Treatment, 2022, 196 : 163 - 173
  • [10] Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
    Whitaker, Kristen D.
    Wang, Xiaoliang
    Ascha, Mustafa
    Showalter, Timothy N.
    Lewin, Heather G.
    Calip, Gregory S.
    Goldstein, Lori J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (01) : 163 - 173
12345